No products in the cart.
Tag: tyrosine kinase inhibitor
#VisualAbstract: Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in ...
Osimertinib associated with longer overall survival versus comparator EGFR-TKIs
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in ...
#VisualAbstract: Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
1. In this phase 3 trial, patients with relapsed or refractory acute myeloid leukemia who received gilteritinib had a longer ...
Gilteritinib more effective than salvage chemotherapy for FLT3-mutated acute myeloid leukemia
1. In this phase 3 trial, patients with relapsed or refractory acute myeloid leukemia who received gilteritinib had a longer ...
Nintedanib may be effective in slowing the progression of interstitial lung disease
1. In this phase 3 trial, patients with fibrosing lung disease who received nintedanib experienced a much slower rate of ...
Quick Take: Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN)
Tenosynovial giant cell tumor (TGCT) is a rare mesenchymal neoplasm that arises in the joints, bursae, or tendon sheaths. The ...
2 Minute Medicine Rewind June 24, 2019
Association Between Preoperative Opioid and Benzodiazepine Prescription Patterns and Mortality After Noncardiac Surgery Strategies to amend clinician prescription patterns are ...
Sorafenib increases progression-free survival in patients with desmoid tumors
1. After 2 years of treatment with sorafenib, patients with desmoid tumors had significantly increased progression-free survival rates compared to ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.